Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Hybrid Robot-Assisted Percutaneous Ablation and Non-Intubated VATS for Multiple Pulmonary Nodules

NCT07395362 · The First Affiliated Hospital of Guangzhou Medical University · Updated 9 Feb 2026

What is being tested
Hybrid Robot-Assisted Percutaneous Intervention and Non-Intubated Video-Assisted Thoracoscopic Surgery
For
Multiple Pulmonary Nodules
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 85 years. About 30 people. The full rules are on the registry page.
Where
China
When
Starts or started 28 Feb 2026, ends 1 Oct 2026. Registered 9 Feb 2026.
Results
None posted yet.

In the researchers' words

The goal of this clinical trial is to evaluate the safety and feasibility of a predefined hybrid treatment strategy in patients with multiple pulmonary nodules who require surgical management of at least one dominant lesion. The strategy combines robot-assisted CT-guided percutaneous ablation and/or localization with non-intubated video-assisted thoracoscopic surgery (NiVATS) performed during the same hospitalization. The main questions this study aims to answer are: Is the hybrid treatment strategy associated with an acceptable rate of perioperative serious complications? Can the planned combination of robot-assisted percutaneous intervention and NiVATS be completed successfully in a real-world clinical setting? Participants will: Undergo preoperative evaluation and multidisciplinary assessment; Receive robot-assisted CT-guided percutaneous ablation and/or localization for selected pulmonary nodules; Undergo non-intubated video-assisted thoracoscopic surgery for resection of the dominant pulmonary lesion; Be followed for perioperative outcomes and short-term recovery up to 30 days after surgery.
ClinicalTrials.gov, NCT07395362

Sites

  • The First Affiliated Hospital of GZMUGuangzhou, China